MSA Safety (MSA) stock stays a Hold amid overvaluation. Learn how fall protection growth and the M&C deal offset NFPA, grant ...
Multiple system atrophy is a rare, progressive neurodegenerative condition for which there is currently no cure. Multiple system atrophy (MSA) is a progressive neurodegenerative disorder with an ...
Researchers visualize alpha-synuclein pathology in living patients with a neurodegenerative disorder
Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by the aggregation of alpha-synuclein in the brain. Now, scientists have developed a radioligand that facilitates the ...
Shy Drager syndrome was the name for the condition now known as multiple system atrophy (MSA), a neurological condition first recognized in the 1960s. It was traditionally diagnosed when someone began ...
YOKNEAM, Israel, May 19, 2025 /PRNewswire/ -- Cytora, a clinical stage company developing unique stem cell treatments based on human Oral Mucosa Stem Cells (hOMSC), reported today data of an ongoing ...
For the first time, scientists have detected α-synuclein aggregates lurking in the brains of the living. This thanks to 18F-ACI-12589, a new tracer developed by AC Immune in Lausanne, Switzerland.
MSAs and HSAs are both tax-exempt savings accounts. HSAs are associated with non-Medicare private insurance plans, while MSAs are linked to Medicare Advantage (Part C) plans. A person enrolled in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback